Download PDF
Thromb Haemost 2019; 119(10): 1642-1654
DOI: 10.1055/s-0039-1693693
Cellular Haemostasis and Platelets
Georg Thieme Verlag KG Stuttgart · New York

Platelet PI3K Modulates Innate Leukocyte Extravasation during Acid-Induced Acute Lung Inflammation

Julia Barbara Kral-Pointner  ‡   *
1   Department for Vascular Biology and Thrombosis Research, Centre for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria
,
Waltraud Cornelia Schrottmaier  ‡   *
1   Department for Vascular Biology and Thrombosis Research, Centre for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria
,
Manuel Salzmann
1   Department for Vascular Biology and Thrombosis Research, Centre for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria
,
Marion Mussbacher
1   Department for Vascular Biology and Thrombosis Research, Centre for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria
,
Georg Johannes Schmidt
2   Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
,
Bernhard Moser 
1   Department for Vascular Biology and Thrombosis Research, Centre for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria
,
Stefan Heber
3   Institute of Physiology, Centre for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria
,
Birgit Birnecker
1   Department for Vascular Biology and Thrombosis Research, Centre for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria
,
Hannah Paar
1   Department for Vascular Biology and Thrombosis Research, Centre for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria
,
Maria Zellner
1   Department for Vascular Biology and Thrombosis Research, Centre for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria
,
Sylvia Knapp
4   CEMM, Research Centre for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
5   Department of Medicine I, Laboratory of Infection Biology, Medical University Vienna, Vienna, Austria
,
Alice Assinger 
1   Department for Vascular Biology and Thrombosis Research, Centre for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria
,
Gernot Schabbauer 
1   Department for Vascular Biology and Thrombosis Research, Centre for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria
› Author Affiliations Funding Financial support was provided by grants of the Austrian Science Fond (FWF) to A.A. and G.S. (P24978, SFB F54) and of the Austrian National Bank to A.A. (OeNB grant 15961). The authors declare no competing financial interests.
Further Information

Publication History

18 January 2019

12 June 2019

Publication Date:
01 August 2019 (online)

    Permissions and Reprints

Corrected by:

ErratumThromb Haemost 2019; 119(10): e1-e1
DOI: 10.1055/s-0040-1702204

Abstract

Introduction Blood platelets are increasingly recognized as modulators of leukocyte effector functions in various pathologies including acute lung injury (ALI). ALI is a life-threatening disease, caused by damage to the alveolar epi- and endothelium. Excessive accumulation of leukocytes leads to severe lung inflammation, resulting in impaired lung function and hypoxemia.

Objective Since leukocyte migration is modulated by activated platelets and phosphatidylinositol 3-kinase (PI3K) signaling is involved in platelet function, we aimed to elucidate the effect of PI3K on platelet-mediated immune responses.

Materials and Methods We generated a mouse model with a platelet-specific deletion of p85α, the most important regulatory subunit of the class IA PI3K, and evaluated platelet function and platelet–leukocyte interactions. Moreover, we analyzed the impact of platelet-specific p85α gene deficiency during sterile peritonitis and acid-induced ALI.

Results In vitro analyses of platelets revealed that lack of p85α led to decreased downstream signaling and diminished expression of surface activation markers, for example, CD62P and CD63, as well as reduced platelet aggregation. Moreover, platelet PI3K essentially mediated direct interactions of platelets with monocytes and neutrophils. In mice, platelet-specific p85α deficiency prevented leukocyte infiltration into the peritoneum and the bronchoalveolar compartment during sterile peritonitis and ALI, respectively. Additionally, the release of the inflammatory cytokine interleukin-12/23 was diminished in platelet p85α-deficient mice during ALI. In contrast to PI3K, neither overexpression nor depletion of platelet phosphatase and tensin homolog, the endogenous antagonist of PI3K, significantly modulated platelet function.

Conclusion Our data indicate a crucial role of platelet PI3K signaling for leukocyte extravasation upon inflammatory stimuli in various diseases models.

Keywords

platelets - PI3K - PTEN - acute lung injury - innate leukocyte recruitment

Authors' Contributions

Experiments performed by J.B.K.P., W.C.S., M.S., M.M., S.H., G.J.S., B.M., B.B., and H.P.; data analyzed and evaluated by J.B.K.P., W.C.S., M.S., and M.M.; data interpreted by J.B.K.P., W.C.S., M.Z., A.A., and G.S.; study designed by J.B.K.P., W.C.S., A.A., G.S., and S.K.; figures compiled by J.B.K.P., W.C.S., M.S., and A.A.; manuscript written by J.B.K.P., W.C.S., and A.A.; study coordinated and funding acquired by A.A. and G.S. All authors read and approved the final version of the manuscript.


* Both the authors contributed equally to the study.


Supplementary Material

 

  • References

  • 1 Weyrich AS, Zimmerman GA. Platelets: signaling cells in the immune continuum. Trends Immunol 2004; 25 (09) 489-495
    CrossrefPubMedGoogle Scholar
  • 2 Zuchtriegel G, Uhl B, Puhr-Westerheide D. , et al. Platelets guide leukocytes to their sites of extravasation. PLoS Biol 2016; 14 (05) e1002459
    CrossrefPubMedGoogle Scholar
  • 3 Weber C. Platelets and chemokines in atherosclerosis: partners in crime. Circ Res 2005; 96 (06) 612-616
    CrossrefPubMedGoogle Scholar
  • 4 Kurose I, Anderson DC, Miyasaka M. , et al. Molecular determinants of reperfusion-induced leukocyte adhesion and vascular protein leakage. Circ Res 1994; 74 (02) 336-343
    CrossrefPubMedGoogle Scholar
  • 5 Zarbock A, Müller H, Kuwano Y, Ley K. PSGL-1-dependent myeloid leukocyte activation. J Leukoc Biol 2009; 86 (05) 1119-1124
    CrossrefPubMedGoogle Scholar
  • 6 Willecke F, Tiwari S, Rupprecht B. , et al. Interruption of classic CD40L-CD40 signalling but not of the novel CD40L-Mac-1 interaction limits arterial neointima formation in mice. Thromb Haemost 2014; 112 (02) 379-389
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Lievens D, Zernecke A, Seijkens T. , et al. Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis. Blood 2010; 116 (20) 4317-4327
    PubMedGoogle Scholar
  • 8 Zirlik A, Maier C, Gerdes N. , et al. CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1. Circulation 2007; 115 (12) 1571-1580
    CrossrefPubMedGoogle Scholar
  • 9 Badrnya S, Schrottmaier WC, Kral JB. , et al. Platelets mediate oxidized low-density lipoprotein-induced monocyte extravasation and foam cell formation. Arterioscler Thromb Vasc Biol 2014; 34 (03) 571-580
    CrossrefPubMedGoogle Scholar
  • 10 Lam FW, Burns AR, Smith CW, Rumbaut RE. Platelets enhance neutrophil transendothelial migration via P-selectin glycoprotein ligand-1. Am J Physiol Heart Circ Physiol 2011; 300 (02) H468-H475
    CrossrefPubMedGoogle Scholar
  • 11 Wetterö J, Tengvall P, Bengtsson T. Platelets stimulated by IgG-coated surfaces bind and activate neutrophils through a selectin-dependent pathway. Biomaterials 2003; 24 (09) 1559-1573
    CrossrefPubMedGoogle Scholar
  • 12 Huo Y, Schober A, Forlow SB. , et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 2003; 9 (01) 61-67
    CrossrefPubMedGoogle Scholar
  • 13 Vardon Bounes F, Mujalli A, Cenac C. , et al. The importance of blood platelet lipid signaling in thrombosis and in sepsis. Adv Biol Regul 2018; 67: 66-73
    CrossrefPubMedGoogle Scholar
  • 14 Domin J, Waterfield MD. Using structure to define the function of phosphoinositide 3-kinase family members. FEBS Lett 1997; 410 (01) 91-95
    CrossrefPubMedGoogle Scholar
  • 15 Watanabe N, Nakajima H, Suzuki H. , et al. Functional phenotype of phosphoinositide 3-kinase p85alpha-null platelets characterized by an impaired response to GP VI stimulation. Blood 2003; 102 (02) 541-548
    CrossrefPubMedGoogle Scholar
  • 16 Zarbock A, Singbartl K, Ley K. Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation. J Clin Invest 2006; 116 (12) 3211-3219
    CrossrefPubMedGoogle Scholar
  • 17 Rubenfeld GD, Caldwell E, Peabody E. , et al. Incidence and outcomes of acute lung injury. N Engl J Med 2005; 353 (16) 1685-1693
    CrossrefPubMedGoogle Scholar
  • 18 Brun-Buisson C, Minelli C, Bertolini G. , et al; ALIVE Study Group. Epidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE study. Intensive Care Med 2004; 30 (01) 51-61
    CrossrefPubMedGoogle Scholar
  • 19 Bernard GR, Artigas A, Brigham KL. , et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149 (3 Pt 1): 818-824
    CrossrefPubMedGoogle Scholar
  • 20 Bakowitz M, Bruns B, McCunn M. Acute lung injury and the acute respiratory distress syndrome in the injured patient. Scand J Trauma Resusc Emerg Med 2012; 20: 54
    CrossrefPubMedGoogle Scholar
  • 21 Kral-Pointner JB, Schrottmaier WC, Horvath V. , et al. Myeloid but not epithelial tissue factor exerts protective anti-inflammatory effects in acid aspiration-induced acute lung injury. J Thromb Haemost 2017; 15 (08) 1625-1639
    CrossrefPubMedGoogle Scholar
  • 22 Salzmann M, Hoesel B, Haase M. , et al. A novel method for automated assessment of megakaryocyte differentiation and proplatelet formation. Platelets 2018; 29 (04) 357-364
    CrossrefPubMedGoogle Scholar
  • 23 Veitinger M, Oehler R, Umlauf E. , et al. A platelet protein biochip rapidly detects an Alzheimer's disease-specific phenotype. Acta Neuropathol 2014; 128 (05) 665-677
    CrossrefPubMedGoogle Scholar
  • 24 Yang H, Wahlmüller FC, Uhrin P. , et al. Proteome analysis of testis from infertile protein C inhibitor-deficient mice reveals novel changes in serpin processing and prostaglandin metabolism. Electrophoresis 2015; 36 (21-22): 2837-2840
    CrossrefPubMedGoogle Scholar
  • 25 Hirsch E, Bosco O, Tropel P. , et al. Resistance to thromboembolism in PI3Kgamma-deficient mice. FASEB J 2001; 15 (11) 2019-2021
    CrossrefPubMedGoogle Scholar
  • 26 Matute-Bello G, Frevert CW, Martin TR. Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol 2008; 295 (03) L379-L399
    CrossrefPubMedGoogle Scholar
  • 27 Fruman DA, Ferl GZ, An SS, Donahue AC, Satterthwaite AB, Witte ON. Phosphoinositide 3-kinase and Bruton's tyrosine kinase regulate overlapping sets of genes in B lymphocytes. Proc Natl Acad Sci U S A 2002; 99 (01) 359-364
    CrossrefPubMedGoogle Scholar
  • 28 Yu J, Zhang Y, McIlroy J, Rordorf-Nikolic T, Orr GA, Backer JM. Regulation of the p85/p110 phosphatidylinositol 3′-kinase: stabilization and inhibition of the p110alpha catalytic subunit by the p85 regulatory subunit. Mol Cell Biol 1998; 18 (03) 1379-1387
    CrossrefPubMedGoogle Scholar
  • 29 Lagrue AH, Francischetti IM, Guimarães JA, Jandrot-Perrus M. Phosphatidylinositol 3′-kinase and tyrosine-phosphatase activation positively modulate Convulxin-induced platelet activation. Comparison with collagen. FEBS Lett 1999; 448 (01) 95-100
    CrossrefPubMedGoogle Scholar
  • 30 Gilio K, Munnix IC, Mangin P. , et al. Non-redundant roles of phosphoinositide 3-kinase isoforms alpha and beta in glycoprotein VI-induced platelet signaling and thrombus formation. J Biol Chem 2009; 284 (49) 33750-33762
    CrossrefPubMedGoogle Scholar
  • 31 Jackson SP, Schoenwaelder SM, Goncalves I. , et al. PI 3-kinase p110beta: a new target for antithrombotic therapy. Nat Med 2005; 11 (05) 507-514
    CrossrefPubMedGoogle Scholar
  • 32 Moore SF, Smith NR, Blair TA, Durrant TN, Hers I. Critical roles for the phosphatidylinositide 3-kinase isoforms p110β and p110γ in thrombopoietin-mediated priming of platelet function. Sci Rep 2019; 9 (01) 1468
    CrossrefPubMedGoogle Scholar
  • 33 Canobbio I, Stefanini L, Cipolla L. , et al. Genetic evidence for a predominant role of PI3Kbeta catalytic activity in ITAM- and integrin-mediated signaling in platelets. Blood 2009; 114 (10) 2193-2196
    PubMedGoogle Scholar
  • 34 Rondina MT, Weyrich AS, Zimmerman GA. Platelets as cellular effectors of inflammation in vascular diseases. Circ Res 2013; 112 (11) 1506-1519
    CrossrefPubMedGoogle Scholar
  • 35 Grommes J, Alard JE, Drechsler M. , et al. Disruption of platelet-derived chemokine heteromers prevents neutrophil extravasation in acute lung injury. Am J Respir Crit Care Med 2012; 185 (06) 628-636
    CrossrefPubMedGoogle Scholar
  • 36 Duerschmied D, Suidan GL, Demers M. , et al. Platelet serotonin promotes the recruitment of neutrophils to sites of acute inflammation in mice. Blood 2013; 121 (06) 1008-1015
    CrossrefPubMedGoogle Scholar
  • 37 Petri B, Broermann A, Li H. , et al. von Willebrand factor promotes leukocyte extravasation. Blood 2010; 116 (22) 4712-4719
    PubMedGoogle Scholar
  • 38 Guo Y, Mishra A, Howland E. , et al. Platelet-derived Wnt antagonist Dickkopf-1 is implicated in ICAM-1/VCAM-1-mediated neutrophilic acute lung inflammation. Blood 2015; 126 (19) 2220-2229
    PubMedGoogle Scholar
  • 39 Ortiz-Muñoz G, Mallavia B, Bins A, Headley M, Krummel MF, Looney MR. Aspirin-triggered 15-epi-lipoxin A4 regulates neutrophil-platelet aggregation and attenuates acute lung injury in mice. Blood 2014; 124 (17) 2625-2634
    PubMedGoogle Scholar
  • 40 Looney MR, Nguyen JX, Hu Y, Van Ziffle JA, Lowell CA, Matthay MA. Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury. J Clin Invest 2009; 119 (11) 3450-3461
    PubMedGoogle Scholar
  • 41 Schrottmaier WC, Kral JB, Badrnya S, Assinger A. Aspirin and P2Y12 Inhibitors in platelet-mediated activation of neutrophils and monocytes. Thromb Haemost 2015; 114 (03) 478-489
    Article in Thieme ConnectPubMedGoogle Scholar
  • 42 Nylander S, Kull B, Björkman JA. , et al. Human target validation of phosphoinositide 3-kinase (PI3K)β: effects on platelets and insulin sensitivity, using AZD6482 a novel PI3Kβ inhibitor. J Thromb Haemost 2012; 10 (10) 2127-2136
    CrossrefPubMedGoogle Scholar
  • 43 Weng Z, Li D, Zhang L. , et al. PTEN regulates collagen-induced platelet activation. Blood 2010; 116 (14) 2579-2581
    PubMedGoogle Scholar
  • 44 Suzuki A, de la Pompa JL, Stambolic V. , et al. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr Biol 1998; 8 (21) 1169-1178
    CrossrefPubMedGoogle Scholar